S&P 500

5.667,20

0,64%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

HSP

Hospira (HSP)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:HSP

<< Anterior 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
28/07/2010	09:47	Dow Jones News	Hospira 2Q Profit Triples On Lower Charges And Higher Revenue	NYSE:HSP
28/07/2010	09:16	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:HSP
28/07/2010	08:54	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:HSP
28/07/2010	08:30	PR Newswire (US)	Hospira Reports Second-Quarter 2010 Results	NYSE:HSP
27/07/2010	16:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:HSP
26/07/2010	11:34	PR Newswire (US)	Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients	NYSE:HSP
22/07/2010	16:10	Dow Jones News	2nd UPDATE: Baxter 2Q Profit Drops 9% As Pressures Continue	NYSE:HSP
22/07/2010	11:18	Dow Jones News	UPDATE: Baxter 2Q Profits Drop 8.9% As Pressures Continue	NYSE:HSP
13/07/2010	18:34	Dow Jones News	UPDATE: Baxter To Replace Pumps Or Pay Refunds Over Two Years	NYSE:HSP
13/07/2010	11:39	PR Newswire (US)	Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections	NYSE:HSP
01/07/2010	09:00	PR Newswire (US)	Hospira Announces Successful Completion of Tender Offer for Shares of Javelin Pharmaceuticals	NYSE:HSP
28/06/2010	20:00	PR Newswire (US)	Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals	NYSE:HSP
24/06/2010	16:00	PR Newswire (US)	Hospira to Host Conference Call for Second-Quarter 2010 Results	NYSE:HSP
22/06/2010	12:29	PR Newswire (US)	Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)	NYSE:HSP
17/06/2010	10:00	PR Newswire (US)	Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals	NYSE:HSP
10/06/2010	11:47	PR Newswire (US)	Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile Neutropenia Associated With Chem	NYSE:HSP
07/06/2010	17:10	PR Newswire (US)	DURECT Corporation Invites You to Join a Conference Call Today Regarding its POSIDUR(TM) Collaboration with Hospira	NYSE:HSP
07/06/2010	17:05	PR Newswire (US)	Hospira and DURECT Sign Agreement to Develop and Commercialize POSIDUR(TM) (SABER(TM)-Bupivacaine) in the U.S. and Canada	NYSE:HSP
19/05/2010	09:55	PR Newswire (US)	Hospira Announces Extension of Tender Offer for Shares of Javelin Pharmaceuticals	NYSE:HSP
18/05/2010	17:46	PR Newswire (US)	Hospira to Present at Upcoming Investor Conferences	NYSE:HSP
14/05/2010	14:47	PR Newswire (US)	Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP	NYSE:HSP
11/05/2010	14:39	PR Newswire (US)	Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders	NYSE:HSP
10/05/2010	12:48	PR Newswire (US)	Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010	NYSE:HSP
06/05/2010	11:32	PR Newswire (US)	Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient S	NYSE:HSP
04/05/2010	05:45	Dow Jones News	2nd UDPATE: Fresenius Medical Backs '10 View Of Higher Profit	NYSE:HSP
27/04/2010	15:33	Dow Jones News	2nd UPDATE: FDA Warns Teva On Manufacturing Violations	NYSE:HSP
27/04/2010	14:32	Dow Jones News	UPDATE: FDA Warns Teva On Manufacturing Violations	NYSE:HSP
27/04/2010	12:06	Dow Jones News	CORRECT: Hospira 1Q Net Off 14% On 2009 Gain; Outlook Raised	NYSE:HSP
27/04/2010	09:54	Dow Jones News	Hospira 1Q Earnings Fell 14% On 2009 Gain; Sales View Cut	NYSE:HSP
27/04/2010	08:34	PR Newswire (US)	Hospira Reports First-Quarter 2010 Results	NYSE:HSP